Keywords: Carcinogenesis; Chemoprevention; Chemotherapy; Oxidative stress; Nrf2; Phytochemicals; AKT; protein kinase B; AMPK; AMP-activated protein kinase; ARE; antioxidant response element; ATF-2; activating transcriptional factor; BBN; N-butyl-N-(4-hydroxybutyl)n
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Astrocytes; CDDP; Autophagy; Proliferation;
Keywords: UCNPs; upconversion nanoparticles; UCPL; upconversion photoluminescence; NIR; near-infrared; Ln3+; lanthanide ions; QDs; quantum dots; CDs; carbon dots; CW; continuous-wavelength; EG; ethylene glycol; QY; quantum yield; CT; X-ray computed tomography; MR;
Keywords: Den; polyamidoamine dendrimer; CDDP; Cis-diamminodichloridoplatinum (II); FA; folic acid; FRA; folate receptor-α; HuR; human antigen R; siRNA; small interfering RNA; PEI; polyethyleneimine; OPDA; O-phenylenediamine; Lung cancer; Dendrimer; FRA; CDDP; HuR
Keywords: Combination chemotherapy; Lung cancer; Mathematical modeling and computational simulation; Gemcitabine and cisplatin; Pharmacokinetics and pharmacodynamics; 2D; Two-dimensional; AUC; Area-under-the-curve; CDDP; Cisplatin (cis-diamminedichloroplatinum(II))
Keywords: Polymeric nanomedicines; Peptide; Cancer therapy; Therapeutic delivery; AF; aminoflavone; ANG; angiopep-2; BBB; blood brain barrier; BCECs; brain capillary endothelial cells; BP; bortezomib-pinanediol; bPEISS; bioreducible branched polyethylenimine; BPLP;
Keywords: Melanoma; CDDP; Starvation; BRAF; Apoptosis;
Keywords: CTD; connective tissue diseases; LC; lung cancer; SLE; systemic lupus erythematosus; PM/DM; polymyositis/dermatomyositis; SSc; systemic sclerosis; ILD; interstitial lung disease; IPF; idiopathic pulmonary fibrosis; AE; acute exacerbation; PS; performance
Competitive reactions among glutathione, cisplatin and copper-phenanthroline complexes
Keywords: A2780; human ovarian carcinoma; C0; [Cu(phen)2(H2O)](ClO4)2; C10; [Cu(phen)(H2O)2(ClO4)2]; CCRF-CEM; human acute T-lymphoblastic leukemia; CDDP; cisplatin or cis-diammineplatinum(II) dichloride; ESI-MS; Electron-Spray Ionisation at Atmopheric-Pressure Mas
Keywords: ABC proteins; ATP-binding cassette proteins; cDDP; cis-diamminedichloroplatinum(II); DOX; doxorubicin; ECn; effective concentration at which n% of control is active; EDTA; ethylenediaminetetraacetic acid; HEPES; 4-(2-hydroxyethyl)-1-piperazineethanesulfon
Keywords: Cisplatin; CDDP; Parsley; Heart; Liver; Oxidative stress; Apoptosis; Antioxidant; Anti-inflammatory;
Keywords: Asp; aspartic acid; ATRP; atom transfer radical polymerization; BM; benzimidazole; CABCL; γ-(carbamic acid benzyl ester)-ε-caprolactone; CaP; calcium phosphate; CD; cyclodextrin; CDDP; cisplatin; CMC; critical micelle concentration; Coenzyme Q10; CoQ10;
Keywords: AASF; Antheraea assama silk fibroin; BC; benzalkonium chloride; BMP-2; bone morphogenetic protein-2; β-TCP; β-tricalcium phosphate; CDDP; cis-diamminedichloroplatinum; CMC; carboxymethylcellulose; E. coli; Escherichia coli; EGF; epidermal growth factor;
Keywords: CDDP; cisplatin; COD; context object discrimination; FC; fear conditioning; NAC; N-acetylcysteine; NOR; novel object recognition; NSCs; neural/stem progenitor cells; ROS; reactive oxygen species; TUNEL; terminal deoxynucleotidyl transferase (TdT) dUTP Nic
Keywords: LAG; lipiodol lymphangiography; CT; computerized tomography; POD; postoperative day; UICC; the Union for International Cancer Control; CDDP; cisplatin; 5-FU; 5-fluorouracil; Intranodal lymphangiography; Lipiodol; Postoperative chylothorax;
Keywords: Cisplatin; Ototoxicity; Vestibulotoxicity; Vestibulo-ocular reflex; Vestibular; OKN; CDDP;
Keywords: Radiotherapy; Ototoxicity; Chemotherapy; Cisplatin; Hearing loss; Hearing; Radioterapia; Ototoxicidade; Quimioterapia; Cisplatina; CDDP; Perda auditiva; Audição;
Keywords: NSCLC; non-small cell lung cancer; CDDP; cisplatin; polymet; polymeric metformin; AMPK; AMP-activated protein kinase; mTOR; mammalian target of rapamycin; ERCC1; excision repair cross-complementation group 1; IV; intravenous; PK; pharmacokinetic; NPs; nan
Keywords: ANF; auranofin; cDDP; cisplatin (cis-diamminedichloroplatinum(II)); Cys; cysteine; DMSO; dimethylsulfoxide; DMEM; Dulbecco's Modified Eagle's Medium; Dp44mT; 2,2â²-Dipyridyl-N,N-dimethylsemicarbazone; FBS; fetal bovine serum; Fe; iron; GPx; glutathio
Keywords: ATP; adenosine triphosphate; CDDP; cis-diamminedichloroplatinum; DOX; doxorubicin; ETC; electron transfer chain; EGFR; epidermal growth factor receptors; ESR; electron spin resonance; EA; electron affinity; ECM; cell-extracellular matrix; FLG; few layer g
Keywords: ACPP; activated cell-penetrating peptide; AFM; atomic force microscopy; AN; angiopeptin; ANP; NP modified with ACPP peptide; APE-1; apurinic endonuclease-1; AU; gold; AUC; area under the curve; AUNP; gold nanoparticles; AUNS; gold nanoshells; BAT; brain a
Keywords: ADH; adipic acid dihydrazide; AUNPs; gold nanoparticles; BA; butyric acid; CDDP; cisplatin; CHI; chitosane; CNTs; carbon nanotubes; CPT; camptothecin; CSCs; cancer stem cells; DiPhPE; diphytanoyl-sn-glycero-3-glycerophosphatidyl ethanolamine; DL; drug loa
Keywords: Oral squamous cell carcinoma; CDDP; Radiation; Chemoradiotherapy
Keywords: CDDP; cisplatin; GSH; reduced glutathione; MDA; malondialdehyde; NO; nitric oxide; cTn-I; cardiac troponin; PDE5; phosphodiesterase-5 enzyme; i.p.; intraperitoneally; cAMP; cyclic adenosine monophosphate; cGMP; cyclic guanosine monophosphate; CAD; coronar
Keywords: Claudin; Tight junction; Antibody therapy; Microenvironment; MIUC; muscle invasive urothelial cancers; CLDN; claudin; SPR; surface plasmon resonance; CDDP; cisplatinum; EGFR; epidermal growth factor receptor; ERK; extracellular signal-regulated kinase; EG
Keywords: BTCC; S-[N-benzyl(thiocarbamoyl)]-l-cysteine; CDDP; cisplatin; HO-1; heme oxygenase-1; PTCC; S-[N-(3-phenylpropyl)(thiocarbamoyl)]-l-cysteine; SnPPIX; tin protoporphyrin IX; Heme oxygenase-1; Cisplatin; Apoptosis; Tubular epithelial cells; Nephrotoxicity;
Keywords: Acetylcholinesterase; AChE antisense RNA; Epigenetic modulation; Apoptosis; Cis-platin; Mitomycin C; AChE; acetylcholinesterase; S-AChE; synaptic acetylcholinesterase; R-AChE; read-through acetylcholinesterase; E-AChE; erythrocyte acetylcholinesterase; AZ
Suture granulomas developing after the treatment of oral squamous cell carcinoma
Keywords: CDDP; cisplatin; CT; computed tomography; US; ultrasonography; PET; positron emission tomography; Suture granuloma; Foreign body granuloma; Absorbable sutures; Chemoradiation; Oral squamous cell carcinoma; Neck dissection;
A case of separation surgery with drainage tube-less (DRESS) esophagostomy for advanced cancer with a respiratory fistula
Keywords: DRESS; drainage tube-less; ERF; esophagorespiratory fistula; EPF; esophagopulmonary fistula; CRT; chemoradiotherapy; CT; computed tomography; EMS; expandable metallic stent; PET-CT; positron emission tomography-CT; CDDP; cisplatin; 5-FU; 5-fluorouracil; C
Chrysin: Sources, beneficial pharmacological activities, and molecular mechanism of action
Keywords: Passifloraceae; Passiflora caerulea; Chrysin; Pharmacological activities; Bioavailability; Molecular docking; AC; adenylyl cyclase; AGEs; advanced glycation end products; ACR; acrylamide; AHR; aryl hydrocarbon receptor; AMPK; AMP-activated protein kinase;
Emerging roles and mechanisms of FOXC2 in cancer
Keywords: FOXC2; Forkhead box protein C2; EMT; epithelial-mesenchymal transition; NSCLC; non-small cell lung cancer; EGFR; epidermal growth factor receptor; siRNA; small (or short) interfering RNA; MAPK; mitogen-activated protein kinase; PI3K; phosphatidylinosito
MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen species
Keywords: ATT; adjacent tumor tissues; CDDP; cisplatin; MAFG; musculoaponeurotic fibrosarcoma oncogene family, protein G; miR-7; microRNA-7; NSCLC; non-small-cell lung cancer; qMSP; quantitative methylation-specific PCR; qRT-PCR; quantitative real-time PCR; ROS;
NRAGE confers poor prognosis and promotes proliferation, invasion, and chemoresistance in gastric cancer
Keywords: NRAGE; neurotrophin receptor-interacting melanoma antigen-encoding protein; UICC; Union for International Cancer Control; OS; overall survival; siRNA; small interfering RNA; p-ERK; phospho-extracellular regulated protein kinase; ZO-1; zonula occludens-1;
Manganese(II) complexes of tolfenamic acid or naproxen in polymeric structures or encapsulated in [15-MC-5] manganese(III) metallacrowns: Structure and biological activity
Keywords: 5FU; 5-fluorouracil; BSA; bovine serum albumin; CDDP; cisplatin; CI; Combination Index; CPT-11; irinotecan hydrochloride, trihydrate; CT; calf-thymus; CV; coefficient of variation; DMF; N,N-dimethylformamide; DMSO; dimethylsulfoxide; DRI; dose reduction i
ATF3 and PRAP1 play important roles in cisplatin-induced damages in microvascular endothelial cells
Keywords: GO; Gene Ontology; KEGG; Kyoto Encyclopedia of Genes and Genomes; DEGs; differentially expressed genes; CDDP; cisplatin; CVD; cardiovascular disease; ATF3; Activating Transcription Factor 3; PRAP1; proline-rich acidic protein 1; HMEC-1; human microvascula
Activity profile of the cisplatin analogue PN149 in different tumor cell lines
Keywords: CDDP; Cisplatin [Cis-Diammine-Dichloroplatinum(II)]; PN149; e-ammine-d-(3-amino-2,2,5,5-tetramethylpyrrolidine-1-oxyl; a; f-bis (butanoato); b; c-dichloroplatinum(IV); Platinum resistance; Cisplatin analogues; Platinum nitroxyl complexes; Gene expression
Novel combined Ato-C treatment synergistically suppresses proliferation of Bcr-Abl-positive leukemic cells in vitro and in vivo
Keywords: Arsenic trioxide; Cisplatin; Combination therapy; Bcr-Abl-positive leukemia; Apoptosis; APL; acute promyelocytic leukemia; ATO; arsenic trioxide; Ato-C; ATO/CDDP; CDDP; Cisplatin; CI; combination index; DRI; dose-reduction index; CML; Chronic myelogenous
Smart polymersomes and hydrogels from polypeptide-based polymer systems through α-amino acid N-carboxyanhydride ring-opening polymerization. From chemistry to biomedical applications
Keywords: ADSCs; adipose derived stem cells; AFM; atomic force microscopy; AG; l/dl-allylglycine; AIBN; 2,2â²-azobisisobutyronitrile; Ala; alanine; ATR-FTIR; attenuated total reflectance Fourier transform infrared spectroscopy; ATRP; atom transfer radical polymeri
A rapid and sensitive UHPLC-MS/MS method for quantification of 83b1 in plasma and its application to bioavailability study in rats
Keywords: UHPLC-MS/MS; ultra-high performance liquid chromatography tandem mass spectrometry; ESCC; esophageal squamous cell carcinoma; PPAR; peroxisome proliferator-activated receptor; CDDP; cisplatin; COX-2; cyclooxygenase-2; PGH; prostaglandin H; MTS; 3-(4,5-d
Chk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer Cells
Keywords: CDDP; cisplatin; Chk1; checkpoint kinase 1; Chk2; checkpoint kinase 2; γ-H2AX; phosphorylated histone H2AX at Ser 139; LA-12; (OC-6-43)-bis(acetato)(1-adamantylamine)amminedichloroplatinum(IV); PARP; poly (ADP-ribose) polymerase; PBS; phosphate-buffered
Triphenyltin(IV) benzoates with diazenyl/imino scaffold exhibiting remarkable apoptosis mediated by reactive oxygen species
Keywords: ROS; reactive oxygen species; IC50; compound concentrations that produce 50% of cell growth inhibition; MTT; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; DCFH-DA; dichlorodihydrofluorescein diacetate; PI; propidium iodide; CDDP; cisplatin
Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity
Keywords: AITC; allyl isothiocyanate; ALT; alanine transaminase; An V; annexin V; ANOVA; analysis of variances; APC; allophycocyanin; AST; aspartate transaminase; b.w.; body weight; BITC; benzyl isothiocyanate; BTMS; bromotrimethylsilane; BuITC; butyl isothiocyanat
Modulating angiogenesis with integrin-targeted nanomedicines
Keywords: (RGD)m; RGD mimetics; 4-NQO; 4-nitroquinoline 1-oxide; AAA; Abdominal Aortic Aneurysms; ADA; 8-Amino-3,6-Dioxaoctonoic Acid; AH-GDM; Aminohexyl-Geldanamycin; ami; Amide; AP-2α; Activating Protein 2α; ARMS; Alveolar Rhabdomyosarcoma; ATO; Arsenic Trioxid
Modulation of signaling mechanisms in the heart by thioredoxin 1
Keywords: Akt; protein kinase B; AMPK; Adenosine Monophosphate-activated Protein Kinase; Ang-II; Angiotensin-II; AP1; Activator protein 1 (AP-1); ASK1; Apoptosis Signal-regulating kinase; Atg4; Autophagy related-4; ATP; Adenosine Triphosphate; CDDP; cis-diammine-di
Synthesis, crystal structures and antitumor activity of two platinum(II) complexes with methyl hydrazinecarbodithioate derivatives of indolin-2-one
Keywords: Platinum(II) complex; Hydrazinecarbodithioate; Synthesis; Antiproliferative activity; Apoptosis; cDDP; cis-diamminedichloroplatinum(II); DAPI; 4â²,6-diamidino-2-phenylindole; DMSO; dimethyl sulphoxide; EB; ethidium bromide; MTS; 3-(4,5-dimethylthiazol-2-
Hsa-miR-513b-5p suppresses cell proliferation and promotes P53 expression by targeting IRF2 in testicular embryonal carcinoma cells
Keywords: miRNA; microRNA; NT2; testicular embryonal carcinoma cell; IRF2; interferon regulatory transcription factor 2; 3â² UTR; 3â²-untranslated region; NC; negative control; siRNA; small interfering RNA; ISH; in situ hybridization; LNA; locked nucleic acid; DM
Total or partial vertebrectomy for lung cancer invading the spine
Keywords: Lung cancer; Spine; Vertebrectomy; NSCLC; non-small cell lung cancer; CT; computed tomography; MRI; magnetic resonance imaging; PET; positron emission tomography; CDDP; cisplatin; CBDCA; carboplatin;
Original ArticleBenefit of early inflow exclusion during living donor liver transplantation for unresectable hepatoblastoma
Keywords: ACT; adjuvant chemotherapy; ACR; acute cellular rejection; AFP; alpha-fetoprotein; CDDP; cisplatin; CPT-11; irinotecan; eGFR; estimated glomerular filtration rate; HB; hepatoblastoma; HCC; hepatocellular carcinoma; LDLT; living donor liver transplantation
Research paperChanges of essential element content and prevention of cisplatin induced oxidative stress in rat liver by CV247 administration
Keywords: AP-1; transcription factor 1; CDDP; cisplatin, cis-diamminedichloroplatinum II; COX; cyclooxigenase; CV247; copper-manganese gluconate with ascorbic acid and sodium salicylate; DL; detection limit; DV; declared value; FV; finale volume; GSHPx; gluthatione
Research paperDual drug-loaded biofunctionalized amphiphilic chitosan nanoparticles: Enhanced synergy between cisplatin and demethoxycurcumin against multidrug-resistant stem-like lung cancer cells
Keywords: Biodegradable chitosan nanoparticle; CD133; CDDP; Dual-drug delivery; Synergistic effect; Cis-Diaminedichloroplatinum (PubChem CID: 2767); Demethoxycurcumin (PubChem CID: 5469424);